Black Americans are at an increased risk for pancreatic cancer, with an incidence rate that’s 67% higher than any other ethnic or racial group in the United States. (National Cancer Institute) Pancreatic cancer isn’t the only ailment affecting people of color at higher rates.
Join Rolfe as we partner with the Cancer Wellness Center in a candid discussion with Dr. Matthew Dixon, a hepatopancreatobiliary surgeon from Rush University Medical Center. Dr. Dixon will address this disparity issue and share details about the latest advancements in pancreatic surgical practices. You’ll learn:
• Common factors contributing to this disparity
• Why increased communication with at-risk groups matters
• How advancements in pancreatic surgery are affecting patients
• What questions patients should ask their medical team
Featuring Dr. Matthew Dixon, Hepatopancreatobiliary surgeon, Rush University Medical Center
About the Speaker
Matthew Dixon, MDFACS, FSSO, is a Hepatopancreatobiliary surgeon with Rush University Medical Center. He has a passion and interest in the clinical treatment of patients with cancers of the liver, metastatic disease of the liver (such as metastatic colorectal cancer), benign liver tumors, bile duct cancer, pancreatic cancer, pancreatic cysts, neuroendocrine tumors and other types of rare pancreatic tumors.